B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KCNK18

MOLECULAR TARGET

potassium two pore domain channel subfamily K member 18

UniProt: Q7Z418NCBI Gene: 3385671 compounds

KCNK18 (potassium two pore domain channel subfamily K member 18) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KCNK18

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Arachidonic Acid0.691

About KCNK18 as a Drug Target

KCNK18 (potassium two pore domain channel subfamily K member 18) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented KCNK18 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KCNK18 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.